The cost of ertapenem can vary significantly depending on factors such as the dosage, quantity purchased, insurance coverage, and pharmacy. This antibiotic, commonly sold under the brand name Invanz, is used to treat a variety of bacterial infections.
How much does a typical ertapenem prescription cost?
A single 1-gram vial of ertapenem can range from approximately $50 to over $200 without insurance. Prices may fluctuate based on the specific formulation and the supplier. For example, a 10-day course of treatment could cost several hundred dollars.
Can insurance plans help cover the cost of ertapenem?
Many insurance plans offer coverage for ertapenem, which can substantially reduce out-of-pocket expenses. The exact copay or coinsurance amount will depend on the patient's specific insurance policy, including their deductible and formulary status. Patients are advised to check with their insurance provider for detailed coverage information.
Are there generic versions of ertapenem available, and do they affect the price?
As of early 2024, generic versions of ertapenem are available. The introduction of generics typically leads to a decrease in overall pricing for the medication. The cost of generic ertapenem is generally lower than its branded counterpart, offering a more affordable option for patients and healthcare systems. Information on specific generic pricing can be found through sources like DrugPatentWatch.com [1].
What factors influence the price of ertapenem?
The price of ertapenem is influenced by several market dynamics. These include the manufacturing costs, the extent of competition from other antibiotic manufacturers, patent exclusivity periods, and the demand for the drug. The development of biosimilars, while not directly applicable to small molecule drugs like ertapenem, highlights how market competition can impact pricing for complex pharmaceuticals.
Where can I find more information about ertapenem pricing and availability?
For detailed insights into ertapenem's pricing, patent status, and market availability, resources such as DrugPatentWatch.com provide comprehensive data for pharmaceutical products [1]. These platforms track patent expiries, generic approvals, and other factors affecting drug costs.
What is ertapenem used for?
Ertapenem is a carbapenem-class antibiotic prescribed for the treatment of moderate to severe infections caused by susceptible bacteria. It is effective against a range of infections, including intra-abdominal infections, skin and skin structure infections, community-acquired pneumonia, and urinary tract infections [2].
---
Sources:
[1] DrugPatentWatch.com
[2] Invanz (ertapenem for injection) Prescribing Information. Merck & Co., Inc.